The GPC3 vaccine was used in combination with CAR-T therapy, to significantly enhance the therapeutic effect against OC, suggesting that the GPC3 vaccine could be used in combination with several cancer treatments in the future [105]. The gene discussed is GPC3; the disease is cancer.